secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2026-08-06T21:07:12+00:00
Accession:  0001628280-26-054459
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Q2 revenue $9.7M (-3% YoY), net loss $0.7M; withdraws FY2026 guidance on CMS reimbursement uncertainty
--------------------------------------------------------------------------------

- Revenue $9.7M, down 3% from $10.1M in Q2 2025; gross margin 76.2% vs 78.1%.
- GAAP operating loss $(0.3)M vs income $1.4M; net loss $0.7M vs net income $0.6M.
- Adjusted EBITDA $1.2M, down from $3.2M; Ultramist system sales fell to 82 units from 116.
- Ultramist applicator revenue rose 13% to $7.3M, driven by 27% YoY unit volume growth.
- Withdraws FY2026 guidance due to CMS proposed 2027 97610 reimbursement rule; will reassess after final rule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026054459/0001628280-26-054459-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026054459/snwv-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-054459

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer